`

Dynavax Technologies

Biotechnology Research

Specialities :
Infectious diseases
Biodefense
Vaccine manufacturing and vaccines
Last Updated: November 20, 2025
Revenue
$277.25M
funding-icon Total Funding
$200.0M
Size
201 - 500

Frequently Asked Questions About Dynavax Technologies

What does Dynavax technologies do?+

Dynavax is a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines to help protect the world against infectious diseases. The Company has two commercial products, HEPLISAV-B vaccine [Hepatitis B Vaccine (Recombinant), Adjuvanted], which is approved in the U.S. and the European Union for the prevention of infection caused by all known subtypes of hepatitis B virus in adults age 18 years and older, and CpG 1018 adjuvant, currently used in multiple adjuvanted COVID-19 vaccines. Dynavax is advancing CpG 1018 adjuvant as a premier vaccine adjuvant through global research collaborations and partnerships. Current collaborations are focused on adjuvanted vaccines for COVID-19,...

What are Dynavax technologies's specialties? +

Infectious diseases,biodefense,vaccine manufacturing and vaccines

What is Dynavax technologies's industry? +

Dynavax technologies operates in the Biotechnology research industry.

What is Dynavax technologies's revenue? +

Dynavax technologies's revenue is $277.25m

What is Dynavax technologies's company size? +

Dynavax technologies has 201 - 500 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.